Low-dose rivaroxaban plus aspirin for elderly patients with symptomatic peripheral artery disease: is it worth the bleeding risk?

Juqian Zhang

Author

S R Vallabhaneni

Author

Gregory Y H Lip

Author

University of Liverpool Liverpool , United Kingdom of Great Britain & Northern Ireland